The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Purification and Characterization of TAFI, a Thrombin-activable Fibrinolysis Inhibitor
Open accessAbstract
Previous studies demonstrated that tissue plasminogen activator-induced fibrinolysis in vitro is retarded in the presence of prothrombin (II) activation and that the anticoagulant-activated protein C appears profibrinolytic by preventing the formation of thrombin (IIa)-like activity during fibrinolysis. To disclose the molecular connection between the generation of IIa and the inhibition of fibrinolysis, a lysis assay that is sensitive to the antifibrinolytic effect of II activation was developed and was used to purify a 60-kDa single-chain protein from human plasma. Because the lysis of a clot, produced from purified components, is retarded when this protein is present and when II activation occurs in situ, the protein was named TAFI (thrombin-activatable fibrinolysis inhibitor). TAFI is cleaved by IIa yielding 35-, 25-, and 14-kDa products. Amino-terminal sequence analyses identified TAFI as a precursor of a plasma carboxypeptidase B (CPB). Formation of the 35-kDa product correlates with both prolongation of lysis time and CPB-like activity. Prolongation of lysis time saturates at about 125 nM TAFI. Activated TAFI inhibits the activation of Glu-plasminogen but does not prolong the lysis of clots formed in the presence of Lys-plasminogen. 2-Guanidinoethylmercaptosuccinic acid, a competitive inhibitor of CPB, completely inhibits prolongation of lysis by activated TAFI in a purified system and the prolongation induced by II activation in barium-adsorbed plasma. This suggests that TAFI accounts for the antifibrinolytic effect that accompanies prothrombin activation and that activated protein C appears profibrinolytic by attenuating TAFI activation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A new technique for the assay of infectivity of human adenovirus 5 DNA
Graham, F. L., & van der Eb, A. J. (1973) · Virology · doi:10.1016/0042-6822(73)90341-3 · Cited by 9,451
Matsudaira, P. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)61070-1 · Cited by 4,950
Spectroscopic Determination of Tryptophan and Tyrosine in Proteins*
Edelhoch, H. (1967) · Biochemistry · doi:10.1021/bi00859a010 · Cited by 3,436
Protein Purification by Affinity Chromatography
Cuatrecasas, P. (1970) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)63022-4 · Cited by 2,796
High resolution acrylamide gel electrophoresis of histones
Panyim, S., & Chalkley, R. (1969) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(69)90042-3 · Cited by 2,453
Neville, D. M. (1971) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)61792-2 · Cited by 1,989
Surface-dependent reactions of the vitamin K-dependent enzyme complexes
Mann, K., Nesheim, M., Church, W., Haley, P., & Krishnaswamy, S. (1990) · Blood · doi:10.1182/blood.v76.1.1.1 · Cited by 879
Self-citationA simple method for the preparation of homogeneous phospholipid vesicles
Barenholz, Y., Gibbes, D., Litman, B. J., Goll, J., Thompson, T. E., & Carlson, F. D. (1977) · Biochemistry · doi:10.1021/bi00631a035 · Cited by 864
Isolation of a membrane-bound cofactor for thrombin-catalyzed activation of protein C.
Esmon, N. L., Owen, W. G., & Esmon, C. T. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)68276-1 · Cited by 699
COFACTOR PROTEINS IN THE ASSEMBLY AND EXPRESSION OF BLOOD CLOTTING ENZYME COMPLEXES
Mann, K. G., Jenny, R. J., & Krishnaswamy, S. (1988) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.57.070188.004411 · Cited by 536
Cited by
Overview of complement activation and regulation
Noris, M., & Remuzzi, G. (2013) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2013.08.001 · Cited by 864
Fibrinolysis and the control of blood coagulation
Chapin, J. C., & Hajjar, K. A. (2015) · Blood Reviews · doi:10.1016/j.blre.2014.09.003 · Cited by 839
Molecular mechanisms of fibrinolysis
Cesarman‐Maus, G., & Hajjar, K. A. (2005) · British Journal of Haematology · doi:10.1111/j.1365-2141.2005.05444.x · Cited by 748
Bajzar, L., Morser, J., & Nesheim, M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.28.16603 · Cited by 644
Self-citationCross Talk Pathways Between Coagulation and Inflammation
Foley, J. H., & Conway, E. M. (2016) · Circulation Research · doi:10.1161/circresaha.116.306853 · Cited by 589
Oral Contraceptives and the Risk of Venous Thrombosis
Vandenbroucke, J. P., Rosing, J., Bloemenkamp, K. W. M., Middeldorp, S., Helmerhorst, F. M., Bouma, B. N., & Rosendaal, F. R. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105173442007 · Cited by 579
Thrombomodulin Mutations in Atypical Hemolytic–Uremic Syndrome
Delvaeye, M., Noris, M., De Vriese, A., Esmon, C. T., Esmon, N. L., Ferrell, G., Del-Favero, J., Plaisance, S., Claes, B., Lambrechts, D., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810739 · Cited by 554
The Dynamics of Thrombin Formation
Mann, K. G., Butenas, S., & Brummel, K. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000046238.23903.fc · Cited by 520
de Kleijn, E. D., de Groot, R., Hack, C. E., H. Mulder, P. G., Engl, W., Moritz, B., Joosten, K. F. M., & Hazelzet, J. A. (2003) · Critical Care Medicine · doi:10.1097/01.ccm.0000072121.61120.d8 · Cited by 437
What Does It Take to Make the Perfect Clot?
Monroe, D. M., & Hoffman, M. (2006) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000193624.28251.83 · Cited by 431
Thrombin functions during tissue factor–induced blood coagulation
Brummel, K. E., Paradis, S. G., Butenas, S., & Mann, K. G. (2002) · Blood · doi:10.1182/blood.v100.1.148 · Cited by 397
New insights into the molecular mechanisms of the fibrinolytic system
RIJKEN, D. C., & LIJNEN, H. R. (2009) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2008.03220.x · Cited by 382
Thrombin activatable fibrinolysis inhibitor and the risk for deep vein thrombosis
van Tilburg, N. H., Rosendaal, F. R., & Bertina, R. M. (2000) · Blood · doi:10.1182/blood.v95.9.2855.009k02_2855_2859 · Cited by 373
Thrombomodulin-Protein C-EPCR System: Integrated to Regulate Coagulation and Inflammation
de Wouwer, M. V., Collen, D., & Conway, E. M. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000134298.25489.92 · Cited by 369
Thrombomodulin and its role in inflammation
Conway, E. M. (2012) · Seminars in Immunopathology · doi:10.1007/s00281-011-0282-8 · Cited by 322
Coagulation 2006: A Modern View of Hemostasis
Hoffman, M., & Monroe, D. M. (2007) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2006.11.004 · Cited by 291
Lisman, T., Leebeek, F. W. G., Mosnier, L. O., Bouma, B. N., Meijers, J. C. M., Janssen, H. L. A., Nieuwenhuis, H. K., & De Groot, P. G. (2001) · Gastroenterology · doi:10.1053/gast.2001.25481 · Cited by 281
WANG, X., CHENG, Q., XU, L., FEUERSTEIN, G. Z., HSU, M., SMITH, P. L., SEIFFERT, D. A., SCHUMACHER, W. A., OGLETREE, M. L., & GAILANI, D. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01236.x · Cited by 278
Klos, A., Wende, E., Wareham, K. J., & Monk, P. N. (2013) · Pharmacological Reviews · doi:10.1124/pr.111.005223 · Cited by 264
Thrombin, Thrombomodulin and TAFI in the Molecular Link Between Coagulation and Fibrinolysis
Nesheim, M., Wang, W., Boffa, M., Nagashima, M., Morser, J., & Bajzar, L. (1997) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1657557 · Cited by 258
Self-citation
Metadata
- Authors
- Bajzar, L., Manuel, R., & Nesheim, M. E.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 1995-06
- Volume
- 270
- Issue
- 24
- Pages
- 14477-14484
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1977497608
- Cited by
- 680
- References
- 21
- FWCI
- 10.08
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.